---
stepsCompleted: [step-01, step-02, step-03, step-04, step-05, step-06]
inputDocuments:
  - _bmad-output/planning-artifacts/prds/prd-quimiaio-2026-07-05/prd.md
  - _bmad-output/planning-artifacts/architecture/architecture-quimiaio-2026-07-28/ARCHITECTURE-SPINE.md
  - _bmad-output/planning-artifacts/ux-designs/ux-quimiaio-2026-07-10/EXPERIENCE.md
  - _bmad-output/planning-artifacts/ux-designs/ux-quimiaio-2026-07-10/DESIGN.md
  - _bmad-output/planning-artifacts/epics.md
---

# Implementation Readiness Assessment Report

**Date:** 2026-08-02
**Project:** Quimia IO

## Document Inventory

### PRD

**Whole Documents:**
- `prds/prd-quimiaio-2026-07-05/prd.md` — status: final, updated 2026-07-31

No sharded version found. No duplicates.

### Architecture

**Whole Documents:**
- `architecture/architecture-quimiaio-2026-07-28/ARCHITECTURE-SPINE.md` — status: draft, updated 2026-07-30

No sharded version found. No duplicates.

### Epics & Stories

**Whole Documents:**
- `epics.md` — 12 epics (incl. 7b), ~50 stories

No sharded version found. No duplicates.

### UX Design

**Whole Documents:**
- `ux-designs/ux-quimiaio-2026-07-10/EXPERIENCE.md` — status: final, updated 2026-08-02
- `ux-designs/ux-quimiaio-2026-07-10/DESIGN.md` — status: final (visual tokens companion to EXPERIENCE.md, not a duplicate)

No sharded version found. No conflicting duplicates — these are two companion files (behavior spec + visual tokens), not competing whole/sharded versions of the same document.

## Issues Found

None. All four required document types found in exactly one whole-document form each; no sharded/whole conflicts.

**Note:** `ARCHITECTURE-SPINE.md` frontmatter still reads `status: draft` despite its own memlog recording a completed Finalize pass (Reviewer Gate run, triage applied, 2026-07-30). Flagging for the Architecture Alignment step — not treated as a discovery blocker here.

## PRD Analysis

### Functional Requirements

**Phase 1 (54 total — FR-1 through FR-53, plus FR-74a):**

FR-1: Users sign in with nickname/email and password; sessions are tenant-scoped.
FR-2: Admin can create, edit, deactivate users and assign one of the predefined roles (admin, recepcionista, químico in Phase 1).
FR-3: Every screen and API enforces role-based access; unauthorized actions are blocked and logged.
FR-4: Password policy and account controls comply with NOM-024-SSA3 (complexity, no shared accounts).
FR-5: Admin manages the study catalog: code, name, area, sample type, container, method, technique, equipment, patient preconditions, processing days, price, tax flag, and per-study print options for the results PDF.
FR-6: Admin manages the analyte catalog: code, name, result type (numeric, text, calculated, image, document, referenced), unit, decimals, default value, and formula for calculated analytes.
FR-7: Referenced analytes support multiple reference ranges segmented by age range (days/weeks/years) and sex.
FR-8: Admin manages packages/profiles: a named group of studies sold at a package price, with its own preconditions and processing days.
FR-9: Admin manages supporting catalogs: methods, techniques, equipment (model, serial, calibration date), containers, sample types.
FR-10: Admin edits reference ranges inline from the analyte list; every change is recorded in the audit log with author and timestamp.
FR-11: Admin customizes the results PDF header: lab logo, name, address, phone, legal captions, responsible chemist signature.
FR-12: Reception creates patients with full name, birth date (age auto-calculated), sex, phone, email, optional CURP, address, optional photo.
FR-13: Patient search by name, phone, or order folio resolves in real time as the user types.
FR-14: Any field is editable; every edit is captured in the change log.
FR-15: Opening a patient with outstanding debt shows a prominent alert.
FR-16: Patient clinical history lists all results ordered by date, with a trend chart comparing repeated studies of the same type and out-of-range values flagged.
FR-17: A patient can be flagged "sample pending" (e.g., urine to be brought later); receiving the sample triggers the pending charge and routes the order to capture automatically.
FR-18: Reception creates an order by finding or creating the patient inline, assigning a referring doctor (mandatory — corrected 2026-07-31), and adding studies via instant search by code or name.
FR-19: Each order line shows catalog price; the price is editable for that order only — the catalog is never modified from reception.
FR-20: Orders support a percentage discount and per-line price overrides, both audit-logged.
FR-21: An order accepts up to three payment methods (cash, card, transfer, credit) in any combination; partial payment generates a tracked debt.
FR-22: Saving an order generates a unique per-tenant folio, a unique QR token (immutable across edits), and prints three document sets: container/tube labels, payment ticket, work-order template.
FR-23: Orders carry patient observations (fasting, medications) and patient conditions, visible to the chemist during capture.
FR-24: Cash-session gating: no order can be created in a branch without an open cash session.
FR-25: CRUD for referring doctors: name, specialty, professional license (cédula), phone, email, workplace, active flag.
FR-26: Orders can be filtered and listed by referring doctor with a date filter.
FR-27: Chemist finds an order by folio, patient name, or date, and selects a study to capture.
FR-28: Capture supports all analyte types: numeric, text, calculated, image, document, referenced.
FR-29: Out-of-range values highlighted automatically; critical values flagged and require explicit acknowledgment before validation.
FR-30: Tab-key navigation moves between analytes for rapid keyboard capture.
FR-31: Validating a study marks it validated, records validator and timestamp, advances the order in the pipeline when all its studies are validated.
FR-32: A validated result can be invalidated only with a mandatory reason; invalidation and recapture are fully audit-logged.
FR-33: Chemist can preview the results PDF before validating.
FR-34: Study display order in the final PDF is adjustable.
FR-35: The capture list color-codes each study: pending / in progress / validated.
FR-74a: Live unidirectional equipment interfacing (Mindray BC-5150, BS-240Pro) — results post automatically into the matching order/analyte; scoped to these two named instruments only.
FR-36: A board shows all active orders in five columns: Reception → Sample received → In analysis → Validated → Delivered.
FR-37: Cards move by drag & drop; each card shows folio, patient, study chips, elapsed time, current responsible, and a color state.
FR-38: Time alerts: yellow after 45 minutes, red after 90.
FR-39: The board filters by chemist and date and shows a live count per column.
FR-40: Clicking a card opens the full order detail.
FR-41: Delivery screen lists results filtered by date and state, color-coded.
FR-42: Print/email/hand-over with consent gating; delivery recorded with timestamp, channel, user.
FR-43: Debt gating on delivery, except explicit audit-logged admin override.
FR-44: Patient portal via QR/token, DOB confirmation gate, configurable token policy.
FR-45: Delivery history shows the patient's previous comparable results.
FR-46: A cash session must be opened before any order can be created that day in that branch.
FR-47: Every payment registers against the open session; manual in/out movements with a concept are supported.
FR-48: Closing produces a summary by payment method, theoretical vs counted totals, difference, per-seller detail, closing PDF.
FR-49: Historical sessions are queryable and exportable (PDF/Excel).
FR-50: Sales report by period with totals by payment method and by seller, exportable to Excel/PDF.
FR-51: Dashboard shows today's KPIs, 7-day revenue chart, top-5 studies, mini pipeline summary, active alerts, quick actions.
FR-52: The system immutably records six categories of regulated events with actor/timestamp/before-after.
FR-53: Audit log is queryable by admin only, filtered by date and user.

**Phase 2 (19 total, inventoried but not in this readiness scope):** FR-60, FR-61, FR-62, FR-63, FR-70, FR-71, FR-72, FR-73, FR-74b, FR-75, FR-76, FR-77, FR-78, FR-79, FR-80, FR-81, FR-82, FR-83, FR-84.

**Total Phase 1 FRs: 54**

### Non-Functional Requirements

NFR-1: Tenant isolation — every table carries `tenant_id`, RLS active from day one.
NFR-2: Compliance (NOM-024-SSA3) — RBAC, audit traceability, backups, password complexity.
NFR-3: Privacy (LFPDPPP 2025) — privacy notice, consent, ARCO rights, encryption in transit/at rest.
NFR-4: Availability — 99.5% business-hours target, graceful offline degradation.
NFR-5: Performance — search <300ms perceived, order creation <2min, Kanban updates <5s.
NFR-6: Mobile-first PWA — every screen usable on a phone.
NFR-7: Auditability — audit records append-only and immutable.
NFR-8: Data durability — automated daily backups, tested restore.
NFR-9: Language — UI in Spanish (Mexico), all monetary values in MXN.

**Total NFRs: 9**

### Additional Requirements

- Regulatory landscape: NOM-007-SSA3-2011, NOM-024-SSA3-2012, LFPDPPP (2025), CFDI 4.0 (Phase 2 add-on).
- Fixed Phase 1 constraints: $32,000 MXN budget, 17-week timeline, single developer (AI-assisted), no scope additions mid-phase (trade-not-add rule), week-8 tripwire (≥50% of FR groups demoed).
- Greenfield start — no ToronjaLab data migration in Phase 1 scope (optional paid add-on only).
- Explicitly out of Phase 1: invoicing/CFDI (client's existing external-accountant channel continues unchanged).
- Six open questions (OQ-1 through OQ-6) and an eleven-item Assumptions Index, mostly resolved at week-1 discovery or Phase 1 retro — none block Phase 1 architecture or epics as currently scoped.

### PRD Completeness Assessment

Complete and internally consistent. `status: final`, `updated: 2026-07-31`. The one substantive correction found during downstream work (FR-18: doctor referente is mandatory, not optional) has already been applied with a decision-log entry — the document a reader opens today already reflects it, not a pending fix. The sprint-change-proposal from 2026-07-27 (equipment interfacing scope) is also fully absorbed (FR-74a/FR-74b split, FR-22 extension, FR-35 footnote). No gaps found between PRD text and what Epics/Stories (this readiness check's next focus) actually cover.

## Epic Coverage Validation

### Coverage Matrix

| FR Range | PRD Requirement Area | Epic Coverage | Status |
|---|---|---|---|
| FR-1 – FR-4 | Auth, roles, RBAC, password policy | Epic 1, Stories 1.1–1.4 | ✓ Covered |
| FR-5 – FR-11 | Catalogs: studies, analytes, ranges, packages, supporting catalogs, PDF header | Epic 2, Stories 2.1–2.6 | ✓ Covered |
| FR-12 – FR-16 | Patients: create, search, edit, debt alert, clinical history | Epic 3, Stories 3.1–3.5 | ✓ Covered |
| FR-17 | Sample-pending flag | Epic 6, Story 6.5 (moved from originally-scoped Epic 3 during story-writing — flag lives on Order/OrderItem) | ✓ Covered |
| FR-18 – FR-24 | Order creation, pricing, payment, folio/print, cash gating | Epic 6, Stories 6.1–6.4 | ✓ Covered |
| FR-25 – FR-26 | Referring doctors CRUD + filter | Epic 4, Stories 4.1–4.2 | ✓ Covered |
| FR-27 – FR-35 | Results capture, validation, invalidation | Epic 7, Stories 7.1–7.6 | ✓ Covered |
| FR-74a | Live Mindray equipment interfacing | Epic 7b, Stories 7b.1–7b.6 | ✓ Covered |
| FR-36 – FR-40 | Pipeline Kanban | Epic 8, Stories 8.1–8.5 | ✓ Covered |
| FR-41 – FR-45 | Delivery & patient portal | Epic 9, Stories 9.1–9.5 | ✓ Covered |
| FR-46 – FR-49 | Cash sessions | Epic 5, Stories 5.1–5.4 | ✓ Covered |
| FR-50 – FR-51 | Dashboard & reports | Epic 10, Stories 10.1–10.3 | ✓ Covered |
| FR-52 – FR-53 | Audit log | Epic 11, Story 11.1 (viewer + traceability test); the *writing* half of FR-52 is cross-cutting, embedded as an explicit AC in every triggering epic's own stories (1, 2, 5, 6, 7, 9) | ✓ Covered |

**Coverage statistics:** Total Phase 1 FRs: 54. FRs covered in epics: 54. Coverage: **100%**.

### Missing Requirements

None. All 54 Phase 1 FRs trace to at least one story.

### Requirement Found in Epics but Not in PRD

**Order cancellation (`OrderItem.status = cancelado`).** Epic 6's Story 6.6 implements order cancellation (Admin-only, mandatory reason, audit-logged, manual refund via Caja). This was discovered as a gap during story-writing — Architecture's own `OrderItem.status` enum (AD-4) has always included a sixth value, `cancelado`, and PRD FR-41 already assumes cancelled orders exist ("results filtered by date and state (ready, with debt, **cancelled**)") — but no PRD FR explicitly describes who can cancel an order or under what conditions. This is not a defect in the epics/stories work; it's a pre-existing PRD gap that story-writing surfaced. **Recommendation:** retrofit a short FR into the PRD (e.g., an FR-22a alongside FR-22, or a footnote on FR-41) documenting the cancellation rule now captured in Story 6.6, so the PRD stays the source of truth rather than epics.md silently carrying a rule the PRD never stated. Flagging for AJ's decision — not blocking, since the rule itself is already decided and documented in epics.md.

## UX Alignment Assessment

### UX Document Status

Found — `EXPERIENCE.md` (behavior spec) + `DESIGN.md` (visual tokens), both `status: final`, `updated: 2026-08-02` (EXPERIENCE.md bumped this session for the debt-gate correction).

### UX ↔ PRD Alignment

`EXPERIENCE.md`'s own `sources:` frontmatter cites `prd.md`, `addendum.md`, and `sprint-change-proposal-2026-07-27.md` — reconciliation is explicit, not assumed. Cross-checked the four documented Key Flows against PRD FRs:

- Flow 1 (Reception intake + Caja gate) → FR-18, FR-24, FR-46, FR-22 (print-preview) — aligned
- Flow 2 (Capture: evidence gallery, source tags, per-study validation) → FR-28, FR-29, FR-31, FR-74a — aligned
- Flow 3 (Delivery: debt gate + signature pad) → FR-42, FR-43 — aligned (and the debt-gate wording correction made this session brings FR-44's portal behavior and EXPERIENCE.md into agreement)
- Flow 4 (Patient portal, DOB gate) → FR-44 — aligned

No UX requirement found describing a capability absent from the PRD, and no PRD FR with a UI surface left undescribed in UX — the 25 UX-DRs extracted during `bmad-create-epics-and-stories` (Step 1) already cross-referenced every FR with a UI dimension.

### UX ↔ Architecture Alignment

Architecture Spine's Stack table explicitly provisions for UX needs: `@react-pdf/renderer` for tickets/work-orders/container labels (UX-DR7), Serwist for the PWA/offline floor (NFR-6, UX-DR13), SWR polling for Kanban/dashboard real-time (AD-11, matching EXPERIENCE.md's "State Patterns" real-time need). AD-5/AD-6/AD-7 (on-site agent, folio-matching, HMAC auth) directly support the analyte source-tag UX pattern (UX-DR6). No UI component in EXPERIENCE.md found without a corresponding architectural provision.

**Minor documentation-hygiene gap (not functional):** `ARCHITECTURE-SPINE.md`'s frontmatter `sources:` list does not include `EXPERIENCE.md`, even though its own memlog explicitly references the 2026-07-29 UX update pass and treats the capture-screen revision as resolved. The reconciliation happened in substance; the frontmatter citation just wasn't updated to reflect it. Same fix opportunity as the `status: draft` note from Document Discovery — bundle both into one Architecture housekeeping pass.

### Warnings

None blocking. Two housekeeping items noted above (both administrative/frontmatter, not content gaps).

## Epic Quality Review

### A. User Value Focus Check

11 of 12 epics pass cleanly (real user, real screen, real outcome). Two require explicit comment, both already disclosed in `epics.md` itself rather than found fresh here:

- **Epic 2, Epic 4** — labeled `[Foundation/prerequisite, not end-user value]` by the team's own Party Mode review. This is the *correct* handling of a genuine edge case, not a violation: these are Admin-facing CRUD screens (real UI, real actor), not "Setup Database"/"API Development" technical milestones — the distinction the standard actually cares about. Passing with commendation for the honest labeling rather than dressing them up as false user value.
- **Epic 7b, Story 7b.1** — framed "As the platform (foundation for both instruments)," not a human actor. This is the one story in the entire document without a real user. **Minor concern**, not critical: the epic as a whole clearly delivers user value (Story 7b.2/7b.3/7b.5/7b.6 are all "As a Químico," and the whole point of FR-74a is chemist time saved), and 7b.1 is genuinely infrastructure with no natural human actor (an on-site listener process). Recommend leaving as-is rather than forcing an artificial "As a Químico" framing onto a story about HMAC auth and connection handling.

### B. Epic Independence Validation

No violations found. Verified specifically: Epic 7 (Results Capture) runs 100% standalone without Epic 7b or Epic 8 — confirmed by Story 7.1's own minimal entry-point list, built precisely to avoid an Epic 8 dependency. Epic 4 → Epic 6 and Epic 5 → Epic 6 are both *backward* dependencies (Epic 6 depends on earlier epics, never the reverse) — correctly directioned, not a violation. Epic 3's Stories 3.4/3.5 reference Epic 6/7 data but define their own complete, testable empty-state behavior today (see Story Quality below) — they don't require those epics to *function*, only to have richer data later.

### C. Story Quality Assessment

**Sizing:** No epic-sized stories found. Epic 7b (the highest hardware-integration risk) was split three times over two Party Mode rounds specifically to keep each story within a single dev agent's scope (connection/parsing separated from mapping/error-handling, per instrument).

**Independence / forward-dependency check:** Zero critical violations. The pattern used in Epic 3 (Stories 3.4, 3.5) and Epic 5 (Story 5.2) — an AC that renders a defined empty/zero state today, populated later once the epic it reads from ships — is the *correct* form of forward-looking design, not a forward dependency: each story is complete and testable as written, with no "wait for Story X" language. Distinguishing this from a real violation was one of the explicit checks run.

**Acceptance criteria:** Given/When/Then throughout. Error/edge conditions are consistently present, not just happy paths — debt-gate blocking, critical-value acknowledgment, DOB mismatch (fails closed, no hint), signature-pad hardware failure (delivery proceeds, sync deferred), offline banners (Recepción + Captura), BS-240Pro's protocol-unconfirmed fallback. Two instances of under-specified copy were found and accepted as normal implementation detail, not standard violations (Story 1.4's "specific reason," Story 6.1's session-gate message) — neither is a safety- or compliance-critical string, unlike the debt-gate/DOB-mismatch messages, which do carry exact quoted text.

### D. Database/Entity Creation Timing

Compliant. Catalogs are created incrementally as each Epic 2 story needs them (supporting catalogs → Study → Analyte → Packages), not as a single upfront schema dump. No epic creates tables it doesn't immediately use.

### E. Special Implementation Checks

**Starter template:** Architecture explicitly specifies none (`Additional Requirements` in epics.md: "No scaffolding starter template... greenfield Next.js App Router setup per the Stack table"). Correctly, no story is framed as "clone starter template."

**🟠 Major finding — Greenfield project/environment setup has no explicit story.** No starter template exists, but *something* still has to: initialize the Next.js 16.2.11+ repo, wire Prisma 7.x + `adapter-pg` to Neon, configure the dev→preview→production pipeline (Vercel + ephemeral Neon branches per PR, per AD-9), and set typed env config (Zod). Every Epic 1 story (1.1–1.5) implicitly assumes this scaffolding already exists — none of them own it. This is exactly the kind of technical-but-necessary work the standard is right to be suspicious of as a fake "epic," but with zero starter template, it can't be skipped either; it just needs a home. **Recommendation:** either fold it into Story 1.1 as a prerequisite line (least disruptive), or add a lightweight "Story 1.0: Project & Environment Scaffolding" ahead of it — team's call, not decided here since it's a process question, not a content gap.

### F. Best Practices Compliance Checklist Summary

| Check | Result |
|---|---|
| Epics deliver user value | ✓ (Epic 2/4 correctly disclosed as the deliberate exception) |
| Epics function independently | ✓ |
| Stories appropriately sized | ✓ (post Epic 7b split) |
| No forward dependencies | ✓ |
| Tables created only when needed | ✓ |
| Clear, testable acceptance criteria | ✓ |
| Traceability to FRs maintained | ✓ (100% coverage, Step 3) |

## Summary and Recommendations

### Overall Readiness Status

**READY**

### Critical Issues Requiring Immediate Action

None. Zero critical or blocking findings across document discovery, PRD analysis, epic coverage, UX alignment, or epic quality review.

### Findings Requiring a Decision Before/During Sprint Planning

1. **🟠 No explicit greenfield project/environment scaffolding story** (Epic Quality Review, §E). Something must initialize the Next.js/Prisma/Neon/Vercel stack before Story 1.1 can run, and no story currently owns it. Decide: fold into Story 1.1 as a prerequisite line, or add a "Story 1.0." Recommend resolving this at Sprint Planning kickoff, not blocking readiness sign-off.
2. **PRD gap: order cancellation has no formal FR** (Epic Coverage Validation). Story 6.6 already implements the rule (Admin-only, mandatory reason, audit-logged, manual refund); recommend a short retrofit FR (e.g. FR-22a) so the PRD stays the source of truth. Non-blocking — the rule itself is already decided and documented.
3. **Architecture frontmatter housekeeping** (Document Discovery + UX Alignment): `status: draft` despite a completed Finalize pass, and `sources:` not listing `EXPERIENCE.md` despite substantively reconciling against it. Purely administrative — bundle into one pass whenever `bmad-architecture` is next touched.

### Recommended Next Steps

1. Decide the scaffolding-story placement (item 1) — quick call, do it before or during Sprint Planning.
2. Add the order-cancellation FR to the PRD (item 2) — five-minute edit, same pattern as the FR-18 correction already made this session.
3. Proceed to `bmad-sprint-planning` — nothing above blocks it.

### Final Note

This assessment reviewed 4 planning documents (PRD, Architecture, UX ×2, Epics/Stories) across 5 validation dimensions and found 0 critical issues, 1 major issue, and 3 minor/housekeeping items — after two rounds of adversarial Party Mode review and multiple corrections already applied earlier in this session (Epic 7 split, FR-18/FR-17 fixes, audit-log gap closure, debt-gate UX correction, among others). The project is ready to proceed to Phase 4 implementation planning.
